^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

NUP98-RARG fusion

i
Other names: NUP98, Nucleoporin 98 And 96 Precursor 2, Nuclear Pore Complex Protein Nup98-Nup96 2, Nucleoporin 98kDa, Nucleoporin 96, Nup98-Nup96, Nup98-96, NUP96, Nuclear Pore Complex Protein Nup98, GLFG-Repeat Containing Nucleoporin, NUP98/PHF23 Fusion 2 Protein, Nucleoporin 98kD, Nucleoporin 98, NUP196, ADIR2, ADAR2, RARG, Retinoic Acid Receptor Gamma, NR1B3, RARC, Nuclear Receptor Subfamily 1 Group B Member 3, RAR-Gamma, Retinoic Acid Nuclear Receptor Gamma Variant 1, Retinoic Acid Nuclear Receptor Gamma Variant 2, Retinoic Acid Receptor, Gamma
Entrez ID:
Related biomarkers:
almost2years
Journal
|
NUP98 (Nucleoporin 98 And 96 Precursor 2) • RARG (Retinoic Acid Receptor Gamma)
|
NUP98-RARG fusion
|
Venclexta (venetoclax) • azacitidine
over2years
Journal
|
NUP98 (Nucleoporin 98 And 96 Precursor 2) • RARG (Retinoic Acid Receptor Gamma)
|
NUP98-RARG fusion
over2years
A Novel NUP98/RARG Gene Fusion in Pediatric Acute Myeloid Leukemia Resembling Acute Promyelocytic Leukemia. (PubMed, J Pediatr Hematol Oncol)
The young male presented with structural and functional abnormalities similar to hypergranular acute promyelocytic leukemia, but was resistant to all transretinoic acids and arsenic trioxide...Disease management may typically require a joint treatment strategy involving chemotherapy, immunotherapy, and support therapy. In this study, we report the clinical manifestations and experimental results of a 10-year-old male and review other cases of RARG gene rearrangement reported in the literature.
Journal
|
NUP98 (Nucleoporin 98 And 96 Precursor 2) • RARG (Retinoic Acid Receptor Gamma)
|
NUP98-RARG fusion
|
arsenic trioxide